help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LIGHT, R. W.
Right arrow Articles by LANE, K. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LIGHT, R. W.
Right arrow Articles by LANE, K. B.

Am. J. Respir. Crit. Care Med., Volume 162, Number 1, July 2000, 98-104

A Single Intrapleural Injection of Transforming Growth Factor-beta 2 Produces an Excellent Pleurodesis in Rabbits

RICHARD W. LIGHT, DONG-SHENG CHENG, Y. C.(GARY)  LEE, JEFFREY ROGERS, JEFFREY DAVIDSON, and KIRK B. LANE

Department of Medicine, Saint Thomas Hospital, and Center for Lung Research and Pathology, Vanderbilt University, Nashville, Tennessee

The purpose of the present study was to determine whether the intrapleural injection of transforming growth factor beta 2 (TGF-beta 2) would produce a pleurodesis in rabbits. Single intrapleural injections of TGF-beta 2 at doses of 5.00 µg (n = 12), 1.67 µg (n = 10), 0.50 µg (n = 10), or 0.167 µg (n = 4), or of the parenteral buffer alone (n = 5) were given in a volume of 2 ml to New Zealand white rabbits. Chest tubes were left in place for at least 72 h. Pleural fluid was aspirated at 24-h intervals and was measured and subjected to chemical analysis. The animals were killed 14 d after the injection. The intrapleural injection of TGF-beta 2 resulted in a dose-dependent pleurodesis (on a scale of 0 to 4, where 0 = no pleurodesis and 4 = complete pleurodesis) with mean scores of 3.6, 2.6, 1.5, 0.7, and 0.3 for the groups that received 5.0, 1.67, 0.50, and 0.167 µg of TGF-beta 2 and buffer alone, respectively. Intrapleural injection of the larger doses of TGF-beta 2 resulted in the formation of a large amount of pleural fluid. The fluid had a significantly lower white blood cell (WBC) count and lactate dehydrogenase (LDH) level than did the fluid that results from the intrapleural injection of 10 mg/kg doxycycline or 400 mg/kg talc slurry. On the basis of this study we conclude that a single intrapleural injection of TGF-beta 2 induces pleurodesis in a dose-dependent manner. A dose of 5.0 µg produced satisfactory pleurodesis in almost all of the rabbits so treated. Larger doses of TGF-beta 2 induced larger pleural effusions with relatively low pleural fluid WBC counts and LDH levels. The ability of TGF-beta to produce a pleurodesis in patients with recurrent pleural effusions or pneumothorax should be investigated. A single intrapleural injection of TGF-beta 2 may produce a pleurodesis both safely and painlessly.




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C.-L. Chung, J.-R. Sheu, H.-E. Liu, S.-C. Chang, Y.-C. Chou, W.-L. Chen, D.-S. Chou, and G. Hsiao
Dynasore, a Dynamin Inhibitor, Induces PAI-1 Expression in MeT-5A Human Pleural Mesothelial Cells
Am. J. Respir. Cell Mol. Biol., June 1, 2009; 40(6): 692 - 700.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
H. E Davies, Y C G. Lee, and R. J O Davies
Pleurodesis for malignant pleural effusion: talc, toxicity and where next?
Thorax, July 1, 2008; 63(7): 572 - 574.
[Full Text] [PDF]


Home page
Eur Respir JHome page
E. Marchi, F. S. Vargas, M. M. Acencio, L. Antonangelo, E. H. Genofre, and L. R. Teixeira
Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis
Eur. Respir. J., November 1, 2006; 28(5): 929 - 932.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
Z. Zhu, M. L. Hawthorne, Y. Guo, W. Drake, S. Bilaceroglu, H. L. Misra, and R. W. Light
Tissue Plasminogen Activator Combined With Human Recombinant Deoxyribonuclease Is Effective Therapy for Empyema in a Rabbit Model
Chest, June 1, 2006; 129(6): 1577 - 1583.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
O. Dikensoy, Z. Zhu, E. Donnelly, G. T. Stathopoulos, K. B. Lane, and R. W. Light
Combination Therapy With Intrapleural Doxycycline and Talc in Reduced Doses Is Effective in Producing Pleurodesis in Rabbits
Chest, November 1, 2005; 128(5): 3735 - 3742.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Bilaceroglu, Y. Guo, M. L. Hawthorne, Z. Zhu, G. T. Stathopoulos, K. B. Lane, and R. W. Light
Oral Forms of Tetracycline and Doxycycline Are Effective in Producing Pleurodesis
Chest, November 1, 2005; 128(5): 3750 - 3756.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
Y. B. Guo, I. Kalomenidis, M. Hawthorne, K. S. Parman, K. B. Lane, and R. W. Light
Pleurodesis Is Inhibited by Anti-Vascular Endothelial Growth Factor Antibody
Chest, September 1, 2005; 128(3): 1790 - 1797.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
Z. Zhu, E. Donnelly, O. Dikensoy, H. Misra, S. Bilaceroglu, K. B. Lane, and R. W. Light
Efficacy of Ultrasound in the Diagnosis of Pleurodesis in Rabbits
Chest, August 1, 2005; 128(2): 934 - 939.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
I. Kalomenidis, Y. Guo, K. B. Lane, M. Hawthorne, and R. W. Light
Transforming Growth Factor-{beta}3 Induces Pleurodesis in Rabbits and Collagen Production of Human Mesothelial Cells
Chest, April 1, 2005; 127(4): 1335 - 1340.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. R. Kunz, M. R. Jadus, G. D. Kukes, F. Kramer, V. N. Nguyen, and S. A. Sasse
Intrapleural Injection of Transforming Growth Factor-{beta} Antibody Inhibits Pleural Fibrosis in Empyema
Chest, November 1, 2004; 126(5): 1636 - 1644.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Sartori, D. Tassinari, P. Ceccotti, P. Tombesi, I. Nielsen, L. Trevisani, and V. Abbasciano
Prospective Randomized Trial of Intrapleural Bleomycin Versus Interferon Alfa-2b via Ultrasound-Guided Small-Bore Chest Tube in the Palliative Treatment of Malignant Pleural Effusions
J. Clin. Oncol., April 1, 2004; 22(7): 1228 - 1233.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. S. Allen, L. Cassone, T. M. Lasco, and D. N. McMurray
Effect of Neutralizing Transforming Growth Factor {beta}1 on the Immune Response against Mycobacterium tuberculosis in Guinea Pigs
Infect. Immun., March 1, 2004; 72(3): 1358 - 1363.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
I. Kalomenidis, K. Lane, T. S. Blackwell, Y. Guo, and R. W. Light
Mice Are Resistant to the Induction of a Pleurodesis
Chest, December 1, 2003; 124(6): 2407 - 2408.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. A. Sasse, M. R. Jadus, and G. D. Kukes
Pleural Fluid Transforming Growth Factor-{beta}1 Correlates with Pleural Fibrosis in Experimental Empyema
Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): 700 - 705.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
Y.C.G. Lee, K.B. Lane, O. Zoia, P.J. Thompson, R.W. Light, and T.S. Blackwell
Transforming growth factor-{beta} induces collagen synthesis without inducing IL-8 production in mesothelial cells
Eur. Respir. J., August 1, 2003; 22(2): 197 - 202.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. J. Devin, Y.C. G. Lee, R. W. Light, and K. B. Lane
Pleural Space as a Site of Ectopic Gene Delivery: Transfection of Pleural Mesothelial Cells With Systemic Distribution of Gene Product
Chest, January 1, 2003; 123(1): 202 - 208.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. W. Light
Talc for Pleurodesis?
Chest, November 1, 2002; 122(5): 1506 - 1508.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
Y. C. G. LEE, D. MELKERNEKER, P. J. THOMPSON, R. W. LIGHT, and K. B. LANE
Transforming Growth Factor beta Induces Vascular Endothelial Growth Factor Elaboration from Pleural Mesothelial Cells in Vivo and in Vitro
Am. J. Respir. Crit. Care Med., January 1, 2002; 165(1): 88 - 94.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2000
Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1789 - 1804.
[Full Text] [PDF]


Home page
ThoraxHome page
Y C G Lee, C J Devin, L R Teixeira, J T Rogers, P J Thompson, K B Lane, and R W Light
Transforming growth factor {beta}2 induced pleurodesis is not inhibited by corticosteroids
Thorax, August 1, 2001; 56(8): 643 - 648.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
Y. C. GARY LEE, L. R. TEIXEIRA, C. J. DEVIN, M. A. C. VAZ, F. S. VARGAS, P. J. THOMPSON, K. B. LANE, and R. W. LIGHT
Transforming Growth Factor-{beta}2 Induces Pleurodesis Significantly Faster than Talc
Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 640 - 644.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D.-s. Cheng, Y. C. G. Lee, J. T. Rogers, E. A. Perkett, J. P. Moyers, R. M. Rodriguez, and R. W. Light
Vascular Endothelial Growth Factor Level Correlates With Transforming Growth Factor-{beta} Isoform Levels in Pleural Effusions
Chest, December 1, 2000; 118(6): 1747 - 1753.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
REBUTTAL FROM DR. LIGHT
Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2026a - 2026.
[Full Text]


Home page
ThoraxHome page
Y C G Lee, K B Lane, R E Parker, D S Ayo, J T Rogers, R W Diters, P J Thompson, and R W Light
Transforming growth factor beta 2 (TGFbeta 2) produces effective pleurodesis in sheep with no systemic complications
Thorax, December 1, 2000; 55(12): 1058 - 1062.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2000 American Thoracic Society
  Work-Life